Direxion Daily S&P Biotech Bull 3X ETF
LABUNYSEARCADirexionEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $590.47M
- Expense ratio
- 0.96%
- Dividend yield
- 0.40%
- Holdings
- 173
- 52-week range
- $108.90$341.93
- Volume (live)
- -
- Avg. volume (3M)
- 420.32K
LABU ETF: Direxion Daily S&P Biotech Bull 3X ETF - Price, Holdings & Analysis
Direxion Daily S&P Biotech Bull 3X ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $210.75 - $220.95 |
|---|---|
| 52-Week High | $341.93 |
| 52-Week Low | $108.90 |
| Open | $219.25 |
| Volume (last close) | 245.22K |
| Average Volume (3M) | 420.32K |
| 1 Day Change | −2.14% |
|---|---|
| 1 Month Change | −9.45% |
| 6 Month Change | +19.58% |
| YTD Change | +45.51% |
| 1 Year Change | +100.33% |
| 5 Year Change | −78.32% |
| 10 Year Change | −67.34% |
| Annual Dividend | $0.91 |
|---|---|
| Dividend Yield | 0.40% |
| Last Dividend Ex-Date | Dec 23, 2025 |
| Dividend Growth YoY | +112.12% |
| Years Dividend Growth | 1 |
| Assets (AUM) | $590.47M |
|---|---|
| Expense Ratio | 0.96% |
| Total Holdings | 173 |
| Inception Date | May 27, 2015 |
| 50-Day MA | $269.89 |
|---|---|
| 200-Day MA | $213.62 |
| RSI | 48.12 |
| Stochastic %K | 52.41 |
| Stochastic %D | 25.23 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
LABU at a Glance
Direxion Daily S&P Biotech Bull 3X ETF (LABU) is an equity ETF from Direxion, launched in May 2015. It manages $590.47M in assets and charges a 0.96% expense ratio, about $96 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 173 positions. The largest are Moderna, Inc (MRNA, 1.89%), Twist Bioscience Corporation (TWST, 1.72%) and Natera, Inc. (NTRA, 1.42%). The top 10 holdings make up 13.5% of the fund. By sector it leans toward Healthcare (50.3%) and Other (49.7%). 96.6% of assets are in the United States.
It pays distributions yielding 0.40% at the Oct 23, 2026 close, $0.91 per share over the trailing 12 months. As of the Oct 23, 2026 close, the share price is up 100.3% over one year, down 78.3% over five years and down 67.3% over ten years (price change, excluding distributions).
Frequently Asked Questions About Direxion Daily S&P Biotech Bull 3X ETF
What is the current price of LABU?
The latest LABU price is $219.60 (Oct 23, 2026 close). The 52-week range is $108.90–$341.93. The share price is up 100.3% over the past year (price change, excluding distributions).
What is the expense ratio for LABU?
LABU's annual expense ratio is 0.96%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does LABU pay dividends?
Yes, LABU pays a 0.40% dividend yield (trailing 12 months, at the Oct 23, 2026 close). The most recent ex-dividend date was December 23, 2025. View full dividend history in the Dividends section.
What are the top holdings of LABU?
As of Oct 4, 2026, LABU's largest holdings are Moderna, Inc (1.9%), Twist Bioscience Corporation (1.7%), Natera, Inc. (1.4%) (combined weight: 5.0%). The fund holds 173 total positions. View the complete portfolio breakdown in the Holdings section.
How does LABU compare to similar ETFs?
Compare LABU (0.96% expense ratio, $590M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.